Clinical Trial Update: A Study of ABT-301 Plus Tislelizumab With Bevacizumab in pMMR/Non-MSI-H Locally Advanced or mCRC [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for ABT-301 in combination with tislelizumab and bevacizumab in locally advanced and metastatic colorectal cancer, currently recruiting in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• ABT-301
• Bevacizumab (bevacizumab)
• Tislelizumab (tislelizumab)

Snippet

Sponsor: Anbogen Therapeutics, Inc. | Conditions: Colorectal Cancer (Diagnosis), Colorectal Cancer Metastatic | Phase 1, Phase 2 | Status: RECRUITING